Listeria monocytogenes activated dendritic cell based vaccine for prevention of experimental tumor in mice (original) (raw)
Effect of Listeria Monocytogenes on Tumor Immunotherapy with Dendritic Cells
Jamshid Hadjati
YAKHTEH, 2007
View PDFchevron_right
A Novel Therapy for Melanoma Developed in Mice: Transformation of Melanoma into Dendritic Cells with Listeria monocytogenes
carmen alvarezdominguez
PLOS ONE, 2015
View PDFchevron_right
Exceptional antineoplastic activity of a dendritic-cell-targeted vaccine loaded with a Listeria peptide proposed against metastatic melanoma
carmen alvarez dominguez
Oncotarget, 2016
View PDFchevron_right
Listeria monocytogenes as a Vector for Cancer Immunotherapy
Jorge H Leitão
Vaccines
View PDFchevron_right
Clinical Experience and Recent Advances in the Development of Listeria-Based Tumor Immunotherapies
Yvonne Paterson
Frontiers in Immunology, 2021
View PDFchevron_right
Protective anti-tumour immune responses by murine dendritic cells pulsed with recombinant Tat-carcinoembryonic antigen derived from Escherichia coli
SY Seong
Clinical & Experimental Immunology, 2009
View PDFchevron_right
A Novel Dendritic Cell-Based Cancer Vaccine Produces Promising Results in a Syngenic CC-36 Murine Colon Adenocarcinoma Model
Grace Linnet MuÑoz Montenegro
Journal of Surgical Research, 2007
View PDFchevron_right
Effective Induction of Acquired Resistance to Listeria monocytogenes by Immunizing Mice with In Vivo-Infected Dendritic Cells
Yoichiro Iwakura
Infection and Immunity, 2003
View PDFchevron_right
Listeria monocytogenes protein fraction induces dendritic cells maturation and T helper 1 immune responses
Arezoo Jamali
2014
View PDFchevron_right
Improved Efficacy of a Dendritic Cell-Based Vaccine against a Murine Model of Colon Cancer: The Helper Protein Effect
Nazanin Mojtabavi
Cancer Research and Treatment, 2014
View PDFchevron_right
A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth control in a mouse model
Ananda Mookerjee
BioImpacts
View PDFchevron_right
Immunotherapeutic Potential of Tumor Antigen-Pulsed and Unpulsed Dendritic Cells Generated from Murine Bone Marrow
Timothy Darrow
Cellular Immunology, 1997
View PDFchevron_right
KBMA Listeria monocytogenes is an effective vector for DC-mediated induction of antitumor immunity
Alice Yewdall
2008
View PDFchevron_right
Cancer vaccines based on dendritic cells loaded with tumor-associated antigens
Philippe Moingeon
Cell biology and toxicology, 2001
View PDFchevron_right
Induction of tumor peptide-specific cytotoxic T cells under serum-free conditions by mature human dendritic cells
Helmut Jonuleit
Archives of Dermatological Research, 2000
View PDFchevron_right
Dendritic cell vaccination with a toll-like receptor agonist derived from mycobacteria enhances anti-tumor immunity
Manh Vo
Oncotarget, 2015
View PDFchevron_right
Listeria monocytogenes-Infected Human Dendritic Cells: Uptake and Host Cell Response
Werner Goebel
Infection and Immunity, 2000
View PDFchevron_right
Optimization of Production of Anti-Cancer Vaccines Based on Dendritic Cells
Zélia Silva
2015
View PDFchevron_right
Efficient antitumor immunity derived from maturation of dendritic cells that had phagocytosed apoptotic/necrotic tumor cells
anurag saxena
International Journal of Cancer, 2001
View PDFchevron_right
Listeria-based vaccines can overcome tolerance by expanding low avidity CD8+ T cells capable of eradicating a solid tumor in a transgenic mouse model of cancer
Alexander Rodriguez
Cancer immunity, 2007
View PDFchevron_right
A full scale comparative study of methods for generation of functional Dendritic cells for use as cancer vaccines
Gustav Gaudernack
BMC Cancer, 2007
View PDFchevron_right
Comparative Analysis of Genetically Modified Dendritic Cells and Tumor Cells as Therapeutic Cancer Vaccines
Peter Raspor
Journal of Experimental Medicine, 2000
View PDFchevron_right
Dendritic cell maturation with CpG for tumor immunotherapy
samaneh arab
Iranian journal of immunology : IJI, 2006
View PDFchevron_right
Construction and Characterization of an Attenuated Listeria monocytogenes Strain for Clinical Use in Cancer Immunotherapy
Roger Pechous
Clinical and Vaccine Immunology, 2009
View PDFchevron_right
Tissue localization of tumor antigen-loaded mouse dendritic cells applied as an anti-tumor vaccine and their influence on immune response
Danuta Duś
Folia histochemica et cytobiologica / Polish Academy of Sciences, Polish Histochemical and Cytochemical Society, 2007
View PDFchevron_right
Benefits of gene transduction of granulocyte macrophage colony-stimulating factor in cancer vaccine using genetically modified dendritic cells
Motoki Miyazawa, Kentaro Ueda
International Journal of Oncology, 2007
View PDFchevron_right
Tumor-peptide-pulsed dendritic cells isolated from spleen or cultured in vitro from bone marrow precursors can provide protection against tumor challenge
Franca Ronchese
Cancer Immunology, Immunotherapy, 1997
View PDFchevron_right
IL-12-Engineered Dendritic Cells Serve as Effective Tumor Vaccine Adjuvants in Vivo
Walter Storkus
Annals of the New York Academy of Sciences, 1996
View PDFchevron_right
Bone Marrow‐Derived Dendritic Cells Serve as Potent Adjuvants for Peptide‐Based Antitumor Vaccines
Albert DeLeo
Stem Cells, 1997
View PDFchevron_right